MyOme and Collective Health® Partner to Expand Access to Whole-Genome Based Products for Employers

MyOme and Collective Health® Partner to Expand Access to Whole-Genome Based Products for Employers

05/07/25, 11:23 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgmenlo park
Type
partnership
MyOme has partnered with The Partner Collective by Collective Health to provide lifelong genomic insights to support preventative care and personalized health decisions for employers. The collaboration aims to improve workforce health outcomes through proactive care and empower forward-thinking employers with cutting-edge, personalized, and preventative health tools for their employee benefits.

Company Info

Company
My Ome
Location
menlo park, california, united states
Additional Info
The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among othersMENLO PARK, Calif., June 21, 2022 /PRNewswire/ -- MyOme, a clinical whole genome platform analysis company, today announced that the company has raised $23 million in an oversubscribed series B financing round led by Healthcare Venture Partners, bringing the total raised to over $36M. The MyOme platform will help families understand and manage their risk for inherited disease. MyOme was founded by leaders in the field of genomics, including Matthew Rabinowitz, co-founder of Natera. MyOme is at the forefront of developing clinical applications to support families of all ethnicities." MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases.